Treating beyond NEDA to tackle the unmet need of smouldering MS

Поделиться
HTML-код
  • Опубликовано: 21 окт 2024

Комментарии • 7

  • @andrewreisinger6860
    @andrewreisinger6860 3 года назад +2

    Glad there are smart people like people like this out there!

  • @DrBrandonBeaber
    @DrBrandonBeaber 3 года назад +3

    I am very interested to see how BTK inhibitors work in progressive MS. Preliminarily, drugs like masitinib seem to be somewhat less effective than b-cell depleters in stopping relapses and new MRI lesions. However, they are likely significantly less deleterious (in terms of risk of infection) in the long run in my opinion.

  • @pedrodacostapinto
    @pedrodacostapinto 3 года назад +1

    I wish you and your colleagues sucess !!🙏🙏🙏

  • @mikejames6408
    @mikejames6408 3 года назад

    Thank you, from someone with smouldering MS. Doing what I can, through diet and exercise, to dampen progression, but looking forward to treatments becoming available in due course, as well as remyelination therapies.

  • @ldjt6184
    @ldjt6184 Год назад

    Do any of the current MS DMTs at all touch smouldering MS, such as dimethyl fumarate, perchance?

  • @georgemaniatis4673
    @georgemaniatis4673 3 года назад

    Very good. Thank you.

  • @sandynelson918
    @sandynelson918 3 года назад

    remission soon at a cheaper cost